To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Ajulemic acid effective in reduction of chronic neuropathic pain, with minimal side effects

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2018

Ajulemic acid effective in reduction of chronic neuropathic pain, with minimal side effects

Vol: 7| Issue: 9| Number:15| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A

Pain measurements and side effect profile of the novel cannabinoid ajulemic acid

Neuropharmacology. 2005 Jun;48(8):1164-71

Contributing Authors:
U Schneider M Karst K Salim S Burstein L Hoy

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

21 patients experiencing chronic neuropathic pain were randomly assigned to receive orally administered ajulemic acid (AJA), a synthetic cannabinoid, or placebo for 7 days, with a 7-day baseline period prior to the treatment. They then underwent a 7-day washout period, followed by another 7-day baseline period, and were crossed-over to receive the other intervention for 7 days. Participants were a...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue